0
Upcoming Allied Market Research
2023
Exosomes Market

Exosomes Market

Size, Share, Competitive Landscape and Trend Analysis Report by Type and Service (Kits and Reagents, Instruments, Services, Others), by Biomolecule Type (Non-coding RNAs, The messenger RNA, Proteins/ Peptides, DNA fragments, Lipids, Others) and by Application (Cancer, Neurodegenerative disease, Cardiovascular diseases): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A11425
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Exosomes Market Outlook - 2027

Exosomes particularly referred as the extracellular vesicles that contain constituents like proteins, nucleic acids, DNA, RNA, lipids, metabolites, of the cells that secrete them. They are actually taken up by the distant cells, in which they play different functions with various behavior. They are different from the ectosomes as they are vesicles with the size range of around 40 to 160 nm and the ectosomes are the vesicles with the size range of around 50nm to 1 micrometer. It is used to maintain the homeostasis balance by removing the unnecessary constituents from the cells. It delivers diverse therapeutic payloads including short interfering RNAs, chemotherapeutic agents, antisense oligonucleotides and immune modulators, by an ability to direct the delivery to a desired target. Furthermore, exosome-based liquid biopsy finds its use in diagnosis and determination of the prognosis of the patients with cancer and other disease. The multicomponent analysis of them can also help in finding out the disease progression and response to therapy. Actually, they pose a potential to be a carrier for drug delivery for the target site. They have high biocompatibility and long-term circulation in the body. Likewise, they have various properties, which make them agents that may provide the treatment for various disorders. 

  
COVID-19 Market Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine, have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. 

Top impacting factors: Market Scenario Analysis, Trends, Drivers, Impact Analysis

Increasing prevalence of diseases such as cancer and other types of diseases, are expected to drive the growth of the market. Moreover, technological advancements in the exosome isolation and analytical procedure also boost the growth of the market. Furthermore, rise in the health care expenditure also increases the level of the market. In addition, increase in cancer R&D can fuel the growth of the market. The spread of awareness about healthcare among the population is also helping to increase the growth of the exosomes market. 

However, the technical difficulties in the implementation of exosomes for various tasks and strict regulatory requirements for the approval of the exosomes products in the market are expected to hamper the growth of the exosomes market. 

New product launches to flourish the market:

In August 2020, the filing of an extended FDA investigational new drug application for studying the treatment of the COVID-19 related inflammatory disease using the Kimera’s First in Class XoGlo isolated placental mesenchymal stem cell-based exosomes was announced by the Kimera Labs. 

In June 2020, a global research and option agreement for designing the well-engineered exosome therapeutics to deliver gene therapy, gene editing, RNA technologies of rare diseases were announced by the Sarepta Therapeutics.

Surge in the usage of the exosomes:

Increase in prevalence of cancer and other types of disease is helping to increase the usage of the exosomes. Moreover, the increase in the technical advancements also helps to surge the usage of exosomes. 

   
Key benefits of the report:

  • This study presents the analytical depiction of the global exosomes industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global exosomes market share.
  • The current market is quantitatively analyzed to highlight the global exosomes market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global exosomes market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the exosomes market research report:

  • What are the leading market players active in the exosomes market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Exosomes Market Report Highlights

Aspects Details
By Type and Service
  • Kits and Reagents
  • Instruments
  • Services
  • Others
By Biomolecule Type
  • Non-coding RNAs
  • The messenger RNA
  • Proteins/ Peptides
  • DNA fragments
  • Lipids
  • Others
By Application
  • Cancer
  • Neurodegenerative disease
  • Cardiovascular diseases
By Region
  • North America 
  • Europe 
  • Asia-Pacific 
  • Latin America 
  • The Middle East and Africa 
Key Market Players Danaher Corporation, Miltenyi Biotec, MBL International Corporation, Lonza Group AG, Diagenode SA, Novus Biologicals, Qiagen N.V., Evox Therapeutics Limited Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Hansa BioMed Life Sciences Hitachi Chemical Diagnostics, Inc., others.
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
Related Tags

Purchase Full Report of
Exosomes Market

Start reading.
This Report and over 71,251+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers